HANDHELD SPIROMETRY AS A TOOL FOR GATHERING QUANTITATIVE RESEARCH DATA IN LUNG CANCER.

2.50
Hdl Handle:
http://hdl.handle.net/10755/164682
Category:
Abstract
Type:
Presentation
Title:
HANDHELD SPIROMETRY AS A TOOL FOR GATHERING QUANTITATIVE RESEARCH DATA IN LUNG CANCER.
Author(s):
Chernecky, Cynthia; Mayfield, William; Itkin, E. Lewis
Author Details:
Cynthia Chernecky, RN, PhD, AOCN, FAAN, Professor, Medical College of Georgia, Augusta, Georgia, USA, email: cchernecky@mail.mcg.edu; William Mayfield; E. Lewis Itkin
Abstract:
Topic: Spirometry values (FEV-1, FVC and FEV-1/FVC%) have not been successful in differentiating values from normal subjects, COPD patients and all lung cancer patients combined. No studies have used handheld spirometry, in newly diagnosed and treatment naive patients with non-small-cell lung cancer (NSCLC), in measuring peak expiratory flow (PEF) and forced expiratory ratio (FER). Comparison of these two values, to values taken from the literature for other groups will help determine if PEF and FER values are clinically appropriate in gathering data and use in interventional evaluation. The MicroPlus (TM), handheld spirometry machine, meets/exceeds all American Thoracic Society requirements. Purpose: What are the values of five handheld spirometry tests (FVC, FEV-1, FEV-1/FVC%, PEF and FER) in newly diagnosed persons with non-small-cell lung cancer? How do these values compare to the values in the literature for norms, patients with COPD and lung cancer patients? This study addresses a gap in the literature regarding PEF and FER values and group comparisons. Framework: This translational framework can reveal a cost effective/efficient way to gather data useful in interventional research and clinical settings. Methods: Prospective, descriptive. Convenience sample 23, 15 males and 8 females, newly diagnosed, treatment naive, NSCLC. 48% adenocarcinoma, 39% squamous cell, 13% large cell; Stage I (N=9), II (N=6) or III (N=8). Means were used to develop comparison histograms for 5 spirometry results in patients with NSCLC and 3 other groups whose norms were found in the literature. Limitations include small sample size, different stages of NSCLC, one clinical setting and values from the literature that did not use the same handheld machine. Findings: FVC, FEV-1 and FEV-1/FVC% means were not different in this sample from 3 other groups and this supports the literature. However, PEF and FER mean values were different in patients with NSCLC from 3 other groups. PEF is at least 100 L/minute less and FER is 8 L/second less in persons with NSCLC than all 3 groups. PEF and FER, two handheld spirometry values, could be useful from a diagnostic perspective in lung cancer screening, interventional research and clinical areas of patient care.
Repository Posting Date:
27-Oct-2011
Date of Publication:
27-Oct-2011
Conference Date:
2006
Conference Name:
31st Annual Oncology Nursing Society Congress
Conference Host:
Oncology Nursing Society
Conference Location:
Boston, Massachusetts, USA
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titleHANDHELD SPIROMETRY AS A TOOL FOR GATHERING QUANTITATIVE RESEARCH DATA IN LUNG CANCER.en_GB
dc.contributor.authorChernecky, Cynthiaen_US
dc.contributor.authorMayfield, Williamen_US
dc.contributor.authorItkin, E. Lewisen_US
dc.author.detailsCynthia Chernecky, RN, PhD, AOCN, FAAN, Professor, Medical College of Georgia, Augusta, Georgia, USA, email: cchernecky@mail.mcg.edu; William Mayfield; E. Lewis Itkinen_US
dc.identifier.urihttp://hdl.handle.net/10755/164682-
dc.description.abstractTopic: Spirometry values (FEV-1, FVC and FEV-1/FVC%) have not been successful in differentiating values from normal subjects, COPD patients and all lung cancer patients combined. No studies have used handheld spirometry, in newly diagnosed and treatment naive patients with non-small-cell lung cancer (NSCLC), in measuring peak expiratory flow (PEF) and forced expiratory ratio (FER). Comparison of these two values, to values taken from the literature for other groups will help determine if PEF and FER values are clinically appropriate in gathering data and use in interventional evaluation. The MicroPlus (TM), handheld spirometry machine, meets/exceeds all American Thoracic Society requirements. Purpose: What are the values of five handheld spirometry tests (FVC, FEV-1, FEV-1/FVC%, PEF and FER) in newly diagnosed persons with non-small-cell lung cancer? How do these values compare to the values in the literature for norms, patients with COPD and lung cancer patients? This study addresses a gap in the literature regarding PEF and FER values and group comparisons. Framework: This translational framework can reveal a cost effective/efficient way to gather data useful in interventional research and clinical settings. Methods: Prospective, descriptive. Convenience sample 23, 15 males and 8 females, newly diagnosed, treatment naive, NSCLC. 48% adenocarcinoma, 39% squamous cell, 13% large cell; Stage I (N=9), II (N=6) or III (N=8). Means were used to develop comparison histograms for 5 spirometry results in patients with NSCLC and 3 other groups whose norms were found in the literature. Limitations include small sample size, different stages of NSCLC, one clinical setting and values from the literature that did not use the same handheld machine. Findings: FVC, FEV-1 and FEV-1/FVC% means were not different in this sample from 3 other groups and this supports the literature. However, PEF and FER mean values were different in patients with NSCLC from 3 other groups. PEF is at least 100 L/minute less and FER is 8 L/second less in persons with NSCLC than all 3 groups. PEF and FER, two handheld spirometry values, could be useful from a diagnostic perspective in lung cancer screening, interventional research and clinical areas of patient care.en_GB
dc.date.available2011-10-27T12:05:05Z-
dc.date.issued2011-10-27en_GB
dc.date.accessioned2011-10-27T12:05:05Z-
dc.conference.date2006en_US
dc.conference.name31st Annual Oncology Nursing Society Congressen_US
dc.conference.hostOncology Nursing Societyen_US
dc.conference.locationBoston, Massachusetts, USAen_US
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.